Učitavanje...
Phase II Cancer Prevention Clinical Trials
The development of agents to prevent cancer requires an iterative process of target identification, preclinical testing, and early and late phase clinical trials to establish efficacy and safety. Since phase III definitive efficacy trials with cancer endpoints require a lengthy timeframe and conside...
Spremljeno u:
| Glavni autor: | |
|---|---|
| Format: | Artigo |
| Jezik: | Inglês |
| Izdano: |
2010
|
| Teme: | |
| Online pristup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC2935910/ https://ncbi.nlm.nih.gov/pubmed/20816506 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1053/j.seminoncol.2010.06.015 |
| Oznake: |
Dodaj oznaku
Bez oznaka, Budi prvi tko označuje ovaj zapis!
|